SCHEMBL4745784

SCHEMBL4745784

CNC(CCO)C(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21621515 1.00
SCHEMBL4745785 1.00
SCHEMBL8767807 0.86 NOD1 (0.37)
SCHEMBL8767803 0.86 NOD1 (0.37)
SCHEMBL5220096 0.84 FOLH1 (0.37)
SCHEMBL20905719 0.84 FOLH1 (0.37)
SCHEMBL31325626 0.80 NOD1 (0.37)
SCHEMBL24233166 0.80
SCHEMBL722207 0.80
SCHEMBL1082586 0.80 NOD1 (0.43)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 81 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119158034-A Bicyclic peptide ligands specific for conjugated protein-4 拜斯科技术开发有限公司 2024-12-20 CN claimed
US-20230405134-A1 NOVEL PROTAC CHIMERIC COMPOUND, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME FOR PREVENTING, AMELIORATING, OR TREATING DISEASES THROUGH TARGET PROTEIN DEGRADATION POSTECH Research and Business Development Foundation (KR) 2023-12-21 US claimed
WO-2022005252-A1 NOVEL PROTAC CHIMERIC COMPOUND, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME FOR PREVENTING, AMELIORATING, OR TREATING DISEASES THROUGH TARGET PROTEIN DEGRADATION 포항공과대학교 산학협력단 2022-01-06 WO claimed
CN-112601539-A Bicyclic peptide ligands specific for bindin-4 拜斯科技术开发有限公司 2021-04-02 CN claimed
EP-3752174-A1 FIBROBLAST GROWTH FACTOR ANALOGS AND USES THEREOF University of Florida Research Foundation, Incorporated (US) 2020-12-23 EP claimed
CN-110536696-A PCSK9 vaccine based on new peptide CADILA HEALTHCARE LTD 2019-12-03 CN claimed
WO-2019160910-A1 FIBROBLAST GROWTH FACTOR ANALOGS AND USES THEREOF UNIVERSITY OF FLORIDA RESEARCH FOUNDATION (US) 2019-08-22 WO claimed
WO-2008116294-A1 EXENDIN ANALOGS MATREGEN CORP. (CA) 2008-10-02 WO claimed
CN-116948176-B Method for preparing polyethersulfone by nucleophilic substitution reaction 吉林省聚科高新材料有限公司 2026-04-14 CN disclosed
US-20250222146-A1 Radiopharmaceuticals Targeting Somatostatin Receptor 2 and Uses Thereof RAYZEBIO, INC. (US) 2025-07-10 US disclosed
WO-2025137441-A1 RADIOPHARMACEUTICALS TARGETING SOMATOSTATIN RECEPTOR 2 AND USES THEREOF RAYZEBIO, INC. (US) 2025-06-26 WO disclosed
WO-2025137443-A1 RADIOPHARMACEUTICAL COMPOSITIONS TARGETING SOMATOSTATIN RECEPTORS AND USES THEREOF RAYZEBIO, INC. (US) 2025-06-26 WO disclosed
CN-119405829-A Bicyclic peptide ligands specific for conjugated protein-4 拜斯科技术开发有限公司 2025-02-11 CN disclosed
CN-119158034-A Bicyclic peptide ligands specific for conjugated protein-4 拜斯科技术开发有限公司 2024-12-20 CN disclosed
US-4351763-A Pharmacologically active peptides ELI LILLY AND COMPANY (US) 1982-09-28 US disclosed
EP-0050503-A1 Pharmacologically active pentapeptide derivatives ELI LILLY AND COMPANY (US) 1982-04-28 EP disclosed
US-4322339-A Pharmacologically active peptides ELI LILLY AND COMPANY (US) 1982-03-30 US disclosed
US-4283329-A ANALGESICS ELI LILLY AND COMPANY (US) 1981-08-11 US disclosed
EP-0030848-A2 Pharmacologically active peptides, their preparation and pharmaceutical compositions containing them ELI LILLY AND COMPANY (US) 1981-06-24 EP disclosed
US-4199499-A ANALGESICS ELI LILLY AND COMPANY (US) 1980-04-22 US disclosed